Eris Lifesciences Q3 Results

  • BSE: 540596
  • NSE: ERIS
  • ISIN: INE406M01024
  • Sector: Biotechnology & Drugs
BSE
1,467.4591.30 (6.63%)
Volume22.18 K
Updated: Mon 25 Nov, 2024 | 15:43:15
NSE
1,473.7599.55 (7.24%)
Volume7.45 L
Updated: Mon 25 Nov, 2024 | 15:43:27
Today: 1,388.00
1,488.10
52-Wk: 810.10
1,521.05

Q3 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Eris Lifesciences Q3 Results

    *All figures in crores except per share values
    Fiscal PeriodDec 23Sep 23QoQ CompDec 22YoY Comp
    Total Revenue 486.30505.30-%423.26-%
    Selling/ General/ Admin Expenses Total 98.6798.53-%87.00-%
    Depreciation/ Amortization 45.7242.09-%29.90-%
    Other Operating Expenses Total 123.24131.03-%110.27-%
    Total Operating Expense 356.50366.25-%315.95-%
    Operating Income 129.79139.05-%107.30-%
    Net Income Before Taxes 115.87126.24-%106.54-%
    Net Income 102.74123.43-%101.86-%
    Diluted Normalized EPS 7.549.06-%7.49-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts